mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
VL

Valiant Laboratories Limited

NSE:VALIANTLABBSE:VALIANTLAB
HealthcarePharmaceuticals & Biotechnology
₹125.1
-0.91%1 Oct close
Mkt cap
₹679 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
ConsolidatedStandalone

Consolidated figures

RatioMar 2023Mar 2024Mar 2025Mar 2026
Margins
Gross margin %16.9%7.6%12.6%17%
EBITDA margin %10%-4.6%
-3.5%
2.7%
EBIT margin %10%-5.7%-5.1%0.1%
PAT margin %8.7%0.2%-1.7%-1.4%
Working capital
Receivable days9792197144
Inventory days17221284
Payable days056127174
NWC days114578254
Leverage
Current ratio2.977.763.231.91
Debt to EBITDA1.77——7.03
Debt to equity0.590.320.520.14
Interest coverage153.5-8.6-7.41.4
Asset turnover1.570.530.330.51
Return ratios
Return on assets %13.6%0.1%-0.5%-0.7%
Return on capital employed %23.7%-0.3%-0.4%0.8%
Return on equity %28.9%0.1%-0.9%-1.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.